DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.

Thumbnail Image

Files

DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.pdf (3.47 MB)

Embargo End Date

ICR Authors

Rogers, Rebecca
 Rossanese, Olivia

Authors

Kanu, N
Cerone, MA
Goh, G
Zalmas, L-P
Bartkova, J
Dietzen, M
McGranahan, N
Rogers, R
Law, EK
Gromova, I
Kschischo, M
Walton, MI
Rossanese, OW
Bartek, J
Harris, RS
Venkatesan, S
Swanton, C

Document Type

Journal Article

Date

2016-09-15

Date Accepted

2016-08-09

Abstract

BACKGROUND: The APOBEC3 family of cytidine deaminases mutate the cancer genome in a range of cancer types. Although many studies have documented the downstream effects of APOBEC3 activity through next-generation sequencing, less is known about their upstream regulation. In this study, we sought to identify a molecular basis for APOBEC3 expression and activation. RESULTS: HER2 amplification and PTEN loss promote DNA replication stress and APOBEC3B activity in vitro and correlate with APOBEC3 mutagenesis in vivo. HER2-enriched breast carcinomas display evidence of elevated levels of replication stress-associated DNA damage in vivo. Chemical and cytotoxic induction of replication stress, through aphidicolin, gemcitabine, camptothecin or hydroxyurea exposure, activates transcription of APOBEC3B via an ATR/Chk1-dependent pathway in vitro. APOBEC3B activation can be attenuated through repression of oncogenic signalling, small molecule inhibition of receptor tyrosine kinase signalling and alleviation of replication stress through nucleoside supplementation. CONCLUSION: These data link oncogene, loss of tumour suppressor gene and drug-induced replication stress with APOBEC3B activity, providing new insights into how cytidine deaminase-induced mutagenesis might be activated in tumourigenesis and limited therapeutically.

Citation

Genome biology, 2016, 17 (1), pp. 185 - ?

DOI

10.1186/s13059-016-1042-9

URI

https://repository.icr.ac.uk/handle/internal/3738

Rights

https://creativecommons.org/licenses/by/4.0

Source Title

Publisher

BMC

ISSN

1474-7596

eISSN

1474-760X

Collections

Cancer Therapeutics

Research Team

Signal Transduction & Molecular Pharmacology
Target Evaluation and Molecular Therapeutics

Notes